Cargando…
Deciphering the Ets-1/2-mediated transcriptional regulation of F8 gene identifies a minimal F8 promoter for hemophilia A gene therapy
Amajor challenge in the development of a gene therapy for hemophilia A is the selection of cell type- or tissue-specific promoters to ensure factor VIII (FVIII) expression without eliciting an immune response. As liver sinusoidal endothelial cells are the major FVIII source, understanding the transc...
Autores principales: | Famà, Rosella, Borroni, Ester, Merlin, Simone, Airoldi, Chiara, Pignani, Silvia, Cucci, Alessia, Corà, Davide, Bruscaggin, Valentina, Scardellato, Sharon, Faletti, Stefania, Pelicci, Giuliana, Pinotti, Mirko, Walker, Gillian E., Follenzi, Antonia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Fondazione Ferrata Storti
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8168518/ https://www.ncbi.nlm.nih.gov/pubmed/32467137 http://dx.doi.org/10.3324/haematol.2019.239202 |
Ejemplares similares
-
A Novel Deletion Mutation of the F8 Gene for Hemophilia A
por: Wang, Jingwei, et al.
Publicado: (2022) -
F8 gene inversion and duplication cause no obvious hemophilia A phenotype
por: Li, Shaoying, et al.
Publicado: (2023) -
Genomic alterations in the F8 gene correlating with severe hemophilia A in Egyptian patients
por: Mosaad, Rehab M., et al.
Publicado: (2020) -
Clustered F8 missense mutations cause hemophilia A by combined alteration of splicing and protein biosynthesis and activity
por: Donadon, Irving, et al.
Publicado: (2018) -
Sequence variation data of F8 and F9 genes in functionally validated control individuals: implications on the molecular diagnosis of hemophilia
por: Seo, Ja Young, et al.
Publicado: (2013)